Concepedia

An observational study of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab

Zequn Tong, Yihua Zhang, Kunli Zhou, Ying Zou, Zhenlan Wu, Jiawen Chen, Zheyu Zhuang, Yi‐Fan Zhao, Ting Gong, Chao Ji

Journal of the American Academy of Dermatology · 2023 · 15 citations · 2 references

DOI

Concepts

References

2

Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis

Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen et al. · JAMA Dermatology · 2020 · 388 citations · Full text

, , +12

Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)

Vivian Y. Shi, Tina Bhutani, Luz Fonacier et al. · Journal of the American Academy of Dermatology · 2022 · 93 citations · Full text

, , +15